Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MRTX

Mirati Therapeutics (MRTX) Stock Price, News & Analysis

Mirati Therapeutics logo

About Mirati Therapeutics Stock (NASDAQ:MRTX)

Advanced Chart

Key Stats

Today's Range
$58.70
$58.70
50-Day Range
$58.70
$59.28
52-Week Range
$27.30
$64.41
Volume
N/A
Average Volume
2.76 million shs
Market Capitalization
$4.12 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mirati Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MRTX Stock News Headlines

Mirati Therapeutics Stock Price History
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? Depending on when you watch this new training, crypto income could be hitting your account as early as tonight!
See More Headlines

MRTX Stock Analysis - Frequently Asked Questions

Mirati Therapeutics, Inc. (NASDAQ:MRTX) released its quarterly earnings data on Monday, November, 6th. The biotechnology company reported ($2.49) earnings per share for the quarter, beating analysts' consensus estimates of ($2.83) by $0.34. The business's quarterly revenue was up 203.7% compared to the same quarter last year.

Mirati Therapeutics subsidiaries include these companies: MethylGene, MethylGene Inc., and Mirati Therapeutics B.V..

Based on aggregate information from My MarketBeat watchlists, some other companies that Mirati Therapeutics investors own include American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH), Humana (HUM) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
11/06/2023
Today
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MRTX
CIK
1576263
Fax
N/A
Employees
587
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
($12.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$740.87 million
Net Margins
-1,900.65%
Pretax Margin
-1,899.99%
Return on Equity
-82.15%
Return on Assets
-67.82%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.54
Quick Ratio
7.40

Sales & Book Value

Annual Sales
$12.44 million
Price / Sales
331.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$17.31 per share
Price / Book
3.39

Miscellaneous

Outstanding Shares
70,150,000
Free Float
67,861,000
Market Cap
$4.12 billion
Optionable
Optionable
Beta
0.77

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:MRTX) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners